The European Investment Bank (EIB) has taken a further step forward in backing the Spanish and European biomedical sector. To this end, the EIB will provide Anaconda Biomed, a Barcelona-based medical device startup, with venture debt funding of up to €10 million to support the development of its second generation of catheter for the treatment of acute ischemic stroke (AIS). This is the second venture debt operation in Spain backed by European Guarantee Fund (EGF) — part of the €540 billion EU response to the economic impact of COVID-19.
